← All stocks

OnKure Therapeutics, Inc.

OKUR Net buying
CIK 0001637715 #4079 in the set updated 21 Sep 2026
Bought (120 mo)
$36.39M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.19M
$0.00 on a plan · $98.06K straight out of an exercise
Sold at will
$5.09M
18 of 19 sales
Net
+$31.20M
+$31.30M against sales at will

By person

20 insiders · 59 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
New Enterprise Associates 15, L.P. entity
10% owner
$10.00M (1)
+$10.00M
4,785,494
$21.04M
Novo Holdings A/S entity
10% owner
$10.00M (1)
$709.74K (1)
+$9.29M
3,330,337
$14.64M
Muralidhar Bali
Director
$4.90M (11)
+$4.90M
2,073,957
$9.12M
O'Donnell Niall
Director
$4.00M (2)
+$4.00M
4,252,426
$18.69M
+106.1%
Cormorant Asset Management, LP entity
Former 10% Owner
$3.41M (2)
−$3.41M
0
$0.00
−100.0%
RiverVest Venture Fund III, L.P. entity
10% owner
$3.00M (1)
+$3.00M
2,409,220
$10.59M
+762.5%
ACORN BIOVENTURES, L.P.
10% owner
$2.59M (2)
+$2.59M
2,839,674
$12.48M
+97.2%
Leonard Braden Michael
Former 10% owner of RPHM
$1.73M (11)
+$1.73M
447,815
$1.97M
Johnson Wendy S.
Chief Development Officer
$949.76K (1)
−$949.76K
0
$0.00
Hall Ashley
Chief Development Officer
$98.06K (1) scheduled
−$98.06K
39,600
$174.09K
+312.5%
Cruse Michael
Chief Operating Officer
$67.31K (7)
+$67.31K
45,455
$199.83K
+1,320%
FLESHER GREGORY J.
President and CEO
$64.00K (1)
+$64.00K
109,600
$481.83K
+6,750%
Jindal Vineet R.
Chief Financial Officer
$37.18K (1)
+$37.18K
36,600
$160.90K
+2,188%
Leverone Jason A.
Chief Financial Officer
$14.17K (7)
−$14.17K
18,802
$82.66K
+164.6%
Saccomano Nicholas A
President and CEO
$4.00K (7)
−$4.00K
11,247
$49.45K
+40.6%
GREY MICHAEL G
Director
134,084
$589.47K
+17.7%
Dorenbaum Alejandro
Chief Medical Officer
30,000
$131.89K
+34.2%
Manke Isaac
Director
20,583
$90.49K
Mathers Edward T
Director
15,310
$67.31K
Carruthers R Michael
Director
4,939
$21.71K

No percentages here. This company's share count has moved by a factor of 3.0 over the window, from 13,673,565 to 40,496,309 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
ACORN BIOVENTURES, L.P.
15 May 2025
10% owner
Buy indirect
1,129,730
$1.85
$2.09M
ACORN BIOVENTURES, L.P.
15 May 2025
10% owner
Buy
270,270
$1.85
$500.00K
Leonard Braden Michael
25 Sep 2024
10% owner
Buy indirect
68,746
$1.50
$102.87K
Leonard Braden Michael
24 Sep 2024
10% owner
Buy indirect
29,600
$1.41
$41.87K
Leonard Braden Michael
18 Sep 2024
10% owner
Buy indirect
806
$1.40
$1.13K
Leonard Braden Michael
17 Sep 2024
10% owner
Buy indirect
55,300
$1.36
$75.11K
Leonard Braden Michael
16 Sep 2024
10% owner
Buy indirect
172,747
$1.37
$236.87K
Leonard Braden Michael
13 Sep 2024
10% owner
Buy indirect
150,000
$1.31
$196.95K
Leonard Braden Michael
12 Sep 2024
10% owner
Buy indirect
36,176
$1.40
$50.52K
Leonard Braden Michael
14 Aug 2024
10% owner
Buy indirect
100,487
$1.41
$142.01K
Leonard Braden Michael
13 Aug 2024
10% owner
Buy indirect
171,339
$1.39
$238.59K
Leonard Braden Michael
14 May 2024
10% owner
Buy indirect
335,000
$1.54
$515.90K
Leonard Braden Michael
14 May 2024
10% owner
Buy indirect
79,281
$1.56
$123.68K
O'Donnell Niall
8 May 2023
Director
Buy indirect
125,000
$8.00
$1.00M
Cruse Michael
1 Sep 2022
Chief Operating Officer
Buy indirect
7,500
$3.39
$25.45K
Cruse Michael
31 Aug 2022
Chief Operating Officer
Buy indirect
3,212
$3.21
$10.31K
Cruse Michael
30 Aug 2022
Chief Operating Officer
Buy indirect
1,845
$3.19
$5.89K
Cruse Michael
30 Aug 2022
Chief Operating Officer
Buy
975
$3.16
$3.08K
Cruse Michael
29 Aug 2022
Chief Operating Officer
Buy indirect
1,140
$3.24
$3.69K
Cruse Michael
29 Aug 2022
Chief Operating Officer
Buy
83
$3.24
$268.92
Cruse Michael
25 Aug 2021
Senior VP-Corporate Operations
Buy
2,500
$7.45
$18.62K
FLESHER GREGORY J.
25 Aug 2021
President and CEO
Buy
8,000
$8.00
$64.00K
Jindal Vineet R.
25 Aug 2021
Chief Financial Officer
Buy
5,000
$7.44
$37.18K
Muralidhar Bali
14 Jul 2021
Director
Buy indirect
111,736
$8.50
$949.76K
Muralidhar Bali
23 Jun 2021
Director
Buy indirect
20,710
$9.28
$192.24K
Muralidhar Bali
22 Jun 2021
Director
Buy indirect
14,615
$8.72
$127.49K
Muralidhar Bali
21 Jun 2021
Director
Buy indirect
32,659
$9.03
$294.93K
Muralidhar Bali
8 Jun 2021
Director
Buy indirect
16,605
$9.50
$157.71K
Muralidhar Bali
4 Jun 2021
Director
Buy indirect
257
$9.42
$2.42K
Muralidhar Bali
3 Jun 2021
Director
Buy indirect
12,100
$9.25
$111.94K
Muralidhar Bali
28 May 2021
Director
Buy indirect
14
$9.50
$133.00
Muralidhar Bali
27 May 2021
Director
Buy indirect
1,120
$9.26
$10.37K
Muralidhar Bali
26 May 2021
Director
Buy indirect
5,915
$9.38
$55.50K
Novo Holdings A/S
13 Apr 2021
10% owner
Buy
666,666
$15.00
$10.00M
Muralidhar Bali
13 Apr 2021
Director
Buy indirect
200,000
$15.00
$3.00M
O'Donnell Niall
13 Apr 2021
Director
Buy indirect
200,000
$15.00
$3.00M
New Enterprise Associates 15, L.P.
13 Apr 2021
10% owner
Buy
666,666
$15.00
$10.00M
RiverVest Venture Fund III, L.P.
9 Apr 2021
10% owner
Buy indirect
200,000
$15.00
$3.00M

What was left out

Form 4 filings counted 131
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 13,328,761
Sales filed before the plan box existed 1
History held since 12 Apr 2021